The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Llorian, M.
Right arrow Articles by Mårtensson, I.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Llorian, M.
Right arrow Articles by Mårtensson, I.-L.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2007, 178: 1981-1985.
Copyright © 2007 by The American Association of Immunologists, Inc.


CUTTING EDGE

Cutting Edge: The PI3K p110{delta} Is Required for Down-Regulation of RAG Expression in Immature B Cells1

Miriam Llorian, Zania Stamataki, Susan Hill, Martin Turner and Inga-Lill Mårtensson2

Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom

At the immature B cell stage the BCR signals the down-regulation of the RAG genes and Ig L chain (LC) allelic and isotype exclusion. The signaling pathway that regulates these events is poorly characterized. We demonstrate that immature B cells from mice deficient in the PI3K catalytic subunit p110{delta} fail to suppress RAG expression and inappropriately recombine {kappa} and {lambda} LC loci. In addition, in the presence of the autoantigen, clonal deletion and receptor editing still takes place, demonstrating that these processes are independent of p110{delta}. These results demonstrate a role for p110{delta} in the regulation of RAG gene expression and thereby LC allelic/isotype exclusion.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Medical Research Council and the Biotechnology and Biological Sciences Research Council.

2 Address correspondence and reprint requests to Dr. Inga-Lill Mårtensson, Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, The Babraham Campus, Cambridge CB2 4AT, U.K. E-mail address: lill.martensson{at}bbsrc.ac.uk

3 Abbreviations used in this paper: HC, H chain; LC, L chain; TG, transgene; BM, bone marrow; LN, lymph node.




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. R. Schram, L. E. Tze, L. B. Ramsey, J. Liu, L. Najera, A. L. Vegoe, R. R. Hardy, K. L. Hippen, M. A. Farrar, and T. W. Behrens
B Cell Receptor Basal Signaling Regulates Antigen-Induced Ig Light Chain Rearrangements
J. Immunol., April 1, 2008; 180(7): 4728 - 4741.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.